The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia

The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia

Alzheimer's disease (AD) is a progressive neurodegenerative condition characterized by cognitive decline. Dyslipidemia, a risk factor for AD, may influence the expression of microRNAs (miRs) involved in AD pathogenesis. Thus, the aim of this study was to investigate the effect of dyslipidemia o...

Full description

Saved in:
Bibliographic Details
Main Authors: Shahram Darabi, Enam Alhagh Gorgich, Auob Rustamzadeh, Nafiseh Mohebi, Hossein Mozhdehipanah
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:IBRO Neuroscience Reports
Subjects:
Alzheimer's disease
Dyslipidemia
Biomarker
MiR-133b
MiR-206
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242125000624
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2667242125000624

Similar Items